Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

Jessica Kalra(University of British Columbia), Marcel B. Bally(BC Cancer Agency)

Oncogene

September 13, 2010

10.1038/onc.2010.366

Cited by 49

Related Papers

Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential

|Biochimica et Biophysica Acta (BBA) - Biomembranes|1985|2.1k

The Liposomal Formulation of Doxorubicin

|Methods in enzymology on CD-ROM/Methods in enzymology|2005|421

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

|PLoS ONE|2013|101

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

|Breast Cancer Research|2009|73

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

|International Journal of Nanomedicine|2017|65